Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
5
×
biotech
clinical trials
5
×
fda
life sciences
national
national blog main
national top stories
new york blog main
5
×
allergan
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
europe blog main
indiana blog main
indiana top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
eli lilly
europe top stories
glaxosmithkline
ipo
medical devices
novartis
sanofi
amgen
What
bio
roundup
days
fda
medicines
abbvie’s
acquisitions
adults
ahead
allergan
announced
approved
august
biofourmis
biotech
black
bucks
busy
cancer
celebrate
ceo
chance
class
collabs
companies
continue
corner
covid
daniel
day
deal
debut
decisions
devices
diamond
diamond’s
drugs
forward
gilead
gilead’s
Language
unset
5
×
Current search:
abbvie
×
unset
×
" new york blog main "
×
" clinical trials "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More